Filing Details

Accession Number:
0001209191-22-035010
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-08 16:06:06
Reporting Period:
2022-06-07
Accepted Time:
2022-06-08 16:06:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1700225 J. Vincent Angotti C/O Acelrx Pharmaceuticals, Inc.
25821 Industrial Blvd., Suite 400
Hayward CA 94545
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-07 46,400 $0.22 1,016,919 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.2187 to $0.2241 on June 7, 2022. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.